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Dear Editor,
Levetiracetam is an anti-epileptic second generation drug with a 
unique mechanism of action involving the modulation of neuronal 
vesicle exocytosis1. Alongside its indication for partial epilepsy, it 
has been proposed as mood stabilizer in both manic and depressive 
phases in bipolar disorder. Although its favorable side effects profile, 
up to 16% behavioral signs like agitation and aggression may occur. 
Manic symptoms were already reported in two papers, seeming to be 
a rare yet possible secondary consequence of this agent2,3. We report a 
case of a levetiracetam-induced manic episode in a 58-year-old male 
without previous psychiatric history.
A 58-year-old Caucasian male with a medical history of epilepsy 
since infancy was admitted to Neurology ward for uncontrolled 
epileptic seizures. He was under phenobarbital 100 mg, valproic acid 
1,500 mg and hidantine 300 mg daily treatment. The patient had 
no  prior  personal  or  family history  of  mental health problems. 
Valproic acid was stopped and levetiracetam was initiated and 
augmented till 3,250 mg/d.
Two weeks after discharge, the patient started presenting 
irritability, restlessness, increased psychomotor activity, decreased 
need for sleep, socially disinhibited behavior, intrusive contact with 
strangers and excessive shopping. One month later, he was admitted 
to our psychiatry emergency. As no relevant alterations were found 
on complete imagological and analytic workup, a diagnosis of manic 
episode was established. He was prescribed with quetiapine 250 
mg/d and levetiracetam to 2,000 mg/d with frankly remission of the 
symptoms in 2 weeks.
Manic episodes are usually related with bipolar disorder but 
can be triggered by other disorders4 or substances. Therefore, the 
temporal sequence of events, the age of patient, the absence of 
other concomitant medications (corticosteroids, antihistaminic 
and antidepressants), the negative history of past psychiatric history 
or substance use strongly suggests that the manic episode was 
induced by levetiracetam. Due to its growing use in the clinical field, 
physicians must be aware of possible mood symptoms and behavioral 
disturbances such as mania that may occur secondarily.
This study was performed in accordance with the provisions of 
the Declaration of Helsinki 2008 and was approved by the Ethics 
Committee of Hospital of Braga. We obtained informed written 
consent from the patient authorizing publication. His anonymity 
has been preserved.
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